Cargando…
Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats
BACKGROUND AND AIMS: It has been shown that Faecalibacterium prausnitzii (F. prausnitzii), one of the dominant intestinal bacterial flora, may protect colonic mucosa against the development of inflammation and subsequent inflammatory bowel disease (IBD), with the underlying mechanisms being unclear....
Autores principales: | Zhang, Mingming, Qiu, Xinyun, Zhang, Hao, Yang, Xiaotong, Hong, Na, Yang, Yonghua, Chen, Hui, Yu, Chenggong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183556/ https://www.ncbi.nlm.nih.gov/pubmed/25275569 http://dx.doi.org/10.1371/journal.pone.0109146 |
Ejemplares similares
-
Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells
por: Dikeocha, Ifeoma Julieth, et al.
Publicado: (2022) -
Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
por: Zhang, Mingming, et al.
Publicado: (2016) -
Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?
por: Jia, Wenjing, et al.
Publicado: (2010) -
The importance of Faecalibacterium prausnitzii in human health and diseases
por: Parsaei, M., et al.
Publicado: (2021) -
Exploring clade differentiation of the Faecalibacterium prausnitzii complex
por: Fabbrini, Marco, et al.
Publicado: (2022)